Business description: Eli Lilly and Company

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (19.4%);

- immunology diseases (9.8%);

- neurology (3.3%): primarily drugs used in treating depression and schizophrenia;

- other (2%).

Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

Number of employees: 47,000

Sales by Activity: Eli Lilly and Company

Fiscal Period: December20202021202220232024

Discovery, Dev., Manufacturing, Marketing, and Sales of Pharmaceutical Products

24.54B 28.32B 28.54B 34.12B 45.04B
See all business segments

Geographical breakdown of sales: Eli Lilly and Company

Fiscal Period: December20202021202220232024

United States (U.S.)

14.23B 16.81B 18.19B 21.79B 30.38B

Europe

4.19B 4.78B 4.3B 6.17B 6.92B

Rest of world

2.42B 2.7B 2.85B 2.95B 4.27B

Japan

2.58B 2.37B 1.75B 1.67B 1.81B

China

1.12B 1.66B 1.45B 1.54B 1.66B
See all geographic segments

Executive Committee: Eli Lilly and Company

Manager TitleAgeSince
Chief Executive Officer 57 2016-12-31
President - -
Director of Finance/CFO 48 2024-09-08
Chief Tech/Sci/R&D Officer 50 2021-05-16
Chief Tech/Sci/R&D Officer - 2023-10-15
See ELI LILLY AND COMPANY governance

Composition of the Board of Directors: Eli Lilly and Company

Director TitleAgeSince
Director/Board Member 65 2004-12-31
Director/Board Member 69 2009-03-31
Director/Board Member 53 2011-12-11
Chairman 57 2017-05-31
Director/Board Member 67 2012-06-03
Director/Board Member 63 2016-01-31
Director/Board Member 55 2016-09-30
Director/Board Member 64 2021-01-24
Director/Board Member 52 2021-02-15
Director/Board Member 62 2022-05-14
Composition of the Board of Directors

Shareholders: Eli Lilly and Company

NameEquities%Valuation
Lilly Endowment, Inc.
10.13 %
96,016,978 10.13 % 74 848 M $
Lilly Endowment, Inc.
10.13 %
96,016,978 10.13 % 74 848 M $
Vanguard Fiduciary Trust Co.
8.359 %
79,224,392 8.359 % 61 758 M $
PNC Investments LLC
5.39 %
51,086,636 5.39 % 39 824 M $
BlackRock Advisors LLC
5.251 %
49,767,892 5.251 % 38 796 M $
NameEquities%Valuation
Caixa DTVM SA
0.001404 %
399,230 0.001404 % 10 M $
Western Asset Management Company DTVM Ltda.
0.000551 %
156,709 0.000551 % 4 M $
BRAM - Bradesco Asset Management SA DTVM
0.000164 %
46,605 0.000164 % 1 M $
Safra Asset Management Ltda.
0.000154 %
43,800 0.000154 % 1 M $
XP Allocation Asset Management Ltda.
0.000026 %
7,367 0.000026 % 190 727 $
List of ELI LILLY AND COMPANY shareholders

Holdings: Eli Lilly and Company

NameEquities%Valuation
6,097,792 1.49% 50,889,367 $
16,895,100 16.37% 34,466,004 $
4,000,000 7.19% 18,800,000 $
19,952,740 2.98% 16,445,048 $

Company details: Eli Lilly and Company

Eli Lilly & Co.

Lilly Corporate Center

46285, Indianapolis

+317 276 2000

http://www.lilly.com
address Eli Lilly and Company(LLY)

Group companies: Eli Lilly and Company

NameCategory and Sector
Investment Managers
Eli Lilly (Suisse) SA
Miscellaneous Commercial Services
Pharmaceuticals: Other
Investment Managers
Eli Lilly Vostok SA
See all subsidiaries

Other Pharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
+1.09%+0.99%-15.60%+137.71% 698B
+0.02%+0.11%+5.90%-12.68% 375B
+0.41%-0.10%+13.39%+24.36% 335B
-1.53%+0.35%-54.14%+9.26% 313B
+0.89%-0.04%+6.30%-20.36% 259B
-0.16%-0.89%+0.47%+17.53% 240B
+0.21%-0.27%-13.25%-7.10% 217B
+2.88%+1.86%-33.42%-11.01% 204B
-0.21%+0.01%-6.03%+19.81% 160B
-0.41%+0.67%-8.04%-51.81% 146B
Average +0.30%+0.74%-10.44%+10.57% 294.8B
Weighted average by Cap. +0.39%+0.50%-10.60%+31.62%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
777.66USD
Average target price
951.98USD
Spread / Average Target
+22.42%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Company Eli Lilly and Company